Leslie A. Litzky

faculty photo
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Chief, Section of Medical Pathology, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
Subspecialty Director, Thoracic Pathology, Section of Surgical Pathology, Department of Pathology & Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
Director, Molecular Anatomic Pathology, Division of Anatomic Pathology, Department of Pathology & Laboratory Medicine, Hospital of the University of Pennsylvania
Chief, Section of Surgical Pathology, Department of Pathology & Laboratory Medicine, Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine

Contact information
Department of Pathology & Laboratory Medicine
6 Founders Building
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
Office: (215) 662-3215
Fax: (215) 349-5984
Education:
B.A. (Russian Language and Literature)
Amherst College, Amherst, MA (magna cum laude), 1980.
(Non-Degree Premedical Program)
School of General Studies, Columbia University, New York, NY, 1982.
M.D. (with Distinction)
George Washington University School of Medicine, Washington, DC, 1987.
Post-Graduate Training
Resident, Department of Pathology & Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1987-1990.
Chief Resident, Anatomic Pathology, Department of Pathology & Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1990-1991.
Surgical Pathology Fellow, Department of Pathology, The George Washington University Medical Center, Washington, DC , 1991-1992.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Itmat Expertise

thoracic oncology

Selected Publications

Sterman DH, Alley E, Stevenson JP, Friedberg J, Metzger S, Recio A, Moon EK, Haas AR, Vachani A, Katz SI, Sun J, Heitjan D, Hwang WT, Litzky L, Yearley JH, Tan KS, Papasavvas E, Kennedy P, Montaner L, Cengel KA, Simone CB, Culligan M, Langer C, Albelda SM: Pilot and feasibility trial of immuno-gene therapy of malignant mesothelioma using intrapleural delivery of adenovirus-interferon-alpha combined with chemotherapy. Clin Cancer Res 22(15): 3791-800, Aug 2016.

Kennedy GT, Okusanya OT, Keating JJ, Heitjan DD, Deshpande C, Litzky LA, Albelda SM, Drebin JA, Nie S, Low PS, Singhal S: The optical biopsy: a novel technique for rapid intraoperative diagnosis of primary pulmonary adenocarcinomas. Ann Surg Page: 602-9, 2015.

Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson A, Roggli V, Travis WD, Wick M: Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 137(5): 647-667, 2013.

Zamani P, Kirkpatrick JN, Litzky LA, Verdino RJ: Longevity of implantable devices explanted from patients having autopsy in hospitals. Am J Cardiol 110(11): 1643-1645, 2012.

McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Pare PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC: Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365(17): 1567-75, Oct 2011.

Litzky, LA: Pulmonary neuroendocrine tumors. Surgical Pathology Clinics Mar 2010.

Litzky LA: Pulmonary sarcomatous tumors. Arch Pathol Lab Med 132: 1104-1117 2008.

Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ: Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18: 105-110, 2005.

Katzenstein A-LA, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM.: Usual and non-specific interstitial pneumonia. Pathologic appraisal using biopsy and explant specimens. Am J Surg Pathol 12: 1567-1577, 2002.

Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJY, Pass HI, Kari C, Rodeck U, Rauscher FJ, Kaiser LR, Albelda SM: The Wilms' Tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 146: 344-356, 1995.

back to top
Last updated: 01/24/2024
The Trustees of the University of Pennsylvania